By proceeding, you agree to our Terms of Use and Privacy Policy.
The ADC Linker & Conjugation Summit is a significant event for those involved in developing ADC drugs. With the increasing use of site-specific ADCs, the development of new conjugation technologies and linker chemistry, as well as the expansion of the linker chemistry toolkit, investments in linker and conjugation technologies have become the primary area of focus for ADC drug developers. This summit aims to provide a comprehensive discussion on all aspects of linker and conjugation chemistry, bringing together chemists and bioconjugation experts working in the ADC field to address the challenges they face. The event will feature 80+ pioneers from top companies, such as Seagen, Genentech, and Bolt Biotherapeutics, who will present new technologies and approaches to improve existing technologies, increase stability, prevent aggregation, and control payload release. Additionally, the summit will cover process development and manufacturing challenges to produce a high-quality product at scale. By attending the summit, participants will gain the knowledge to select the right linker and conjugation technology to develop a suite of homogenous ADCs with improved efficacy and lower toxicity, ultimately providing a real-life benefit to patients. The summit will take place in Boston and promises to be an empowering and informative experience.
Discover Innovations in linker & conjugation chemistries to create stable ADCs drugs.
Learn optimizing linker stability within circulation to eliminate off-target toxicities, increase stability & maximize targeted delivery and more.
Be part of interactive sessions to develop a suite of homogenous ADCs that can provide a real-life benefit to patients with improved efficacy and lower toxicity.
Expand your understanding from leading experts to maximize the therapeutic window of ADCs and help bring safe and effective therapies to market faster.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US.
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services f
Singzyme's mission is to deliver on the promise of effective immuno-therapies by developing safer and more homogenous, precision medicines for the well-being of patients worldwide. Singzyme applies its platform technology in the field of immuno-thera
Singzyme's mission is to deliver on the promise of effective immuno-therapies by developing safer and more homogenous, precision medicines for the well-being of patients worldwide. Singzyme applies its platform technology in the field of immuno-therapies with a focus on the conjugation of active mol
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.